Uric Acid and Coronary Artery Disease, Two Sides of a Single Coin: A Determinant of Antioxidant System or a Factor in Metabolic Syndrome
Author:
Open Access
- 1 February 2016
- journal article
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
- Vol. 10 (2) , OC27-31
Abstract
Uric acid has antioxidant activity and it is expected to protect against coronary artery disease (CAD). Contradictory, it is a component of metabolic syndrome and so a risk factor for CAD. The associations of plasma total antioxidant capacity (TAOC) and uric acid (UA) as well as other risk factors were investigated relative to the occurrence and severity of CAD. The study population consisted of 148 males and 152 females aged 35-76 years who were classified as CAD cases and controls according to the results of coronary angiography. The severity of CAD was scored on the basis of the number and the extent of lesions at coronary arteries. The concentrations of UA and TAOC were measured by using of FRAP and enzymatic uricase methods. The prevalence of hypertension, cigarette smoking and diabetes mellitus was more frequent in CAD cases than controls. Patients with CAD when compared with the controls had increased levels of glucose, triglycerides, creatinine, UA, TAOC and decreased levels of HDL- cholesterol. Serum UA was high positive correlate of serum total and LDL-cholesterol, triglyceride, creatinine, BUN, bilirubin, TAOC and negative correlate of glucose and HDL-C. TAOC and its major determinant UA but not bilirubin and albumin are significantly associated with the prevalence and severity of CAD. In multivariate analysis and in the absence of hypertension, UA but not TAOC would remain and be associated with CAD by the OR of 1.57 (1.07-2.29), p=0.02. If the results adjusted for all major risk factors including hypertension, neither TAOC nor UA would remain in the regression equation. The results suggest that TAOC and UA but not bilirubin and albumin are associated with CAD significantly. But, the correlation is not independent and is attributed to the metabolic syndrome. The measurement of UA and TAOC will not improve the prognostic power beyond the classical risk factors.Keywords
This publication has 34 references indexed in Scilit:
- Erythrocyte Antioxidant Defenses Against Cigarette Smoking in Ischemic Heart DiseaseJournal of Clinical and Diagnostic Research, 2015
- Progression of Coronary Artery Disease (CAD) from Stable Angina (SA) Towards Myocardial Infarction (MI): Role of Oxidative StressJournal of Clinical and Diagnostic Research, 2014
- Uric acid and cardiovascular disease risk reclassification: Findings from NHANES IIIEuropean Journal of Preventive Cardiology, 2014
- Hyperuricemia and coronary heart disease: A systematic review and meta‐analysisArthritis Care & Research, 2010
- Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: A prospective 21-year follow-up studyInternational Journal of Cardiology, 2008
- Uric acid and cardiovascular riskCurrent Opinion in Pharmacology, 2002
- Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levelsAtherosclerosis, 2002
- Oxidative stress and cardiac diseaseThe American Journal of Medicine, 2000
- Is serum uric acid a risk factor for coronary heart disease?Journal of Human Hypertension, 1999
- The association between the total antioxidant potential of plasma and the presence of coronary heart disease and renal dysfunction in patients with NIDDMFree Radical Research, 1998